Skip to main content
Premium Trial:

Request an Annual Quote

New Lion CFO Will Begin on April 1

NEW YORK, March 18 - Lion Bioscience on Monday said it has hired Martin Hollenhorst as chief financial officer to replace Klaus Sprockamp, who perished in the Sept. 11 attacks on the World Trade Center here.

Hollenhorst, 43, will "assume overall responsibility for the finance, controlling, and accounting divisions" of Lion as of April 1, the company said.

He comes to Lion from a stint as a freelance management consultant in Washington where he advised German-American companies "on strategic and acquisition matters," according to his new employer.


Before that Hollenhorst was CEO of ANN Systems ASA, a German-American software company.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.